ArticleScientific reports2018

High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer.

Keith H Jansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.